Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Colorcon
McKinsey
Cerilliant
AstraZeneca
Chubb
Fish and Richardson
Johnson and Johnson
Harvard Business School
McKesson

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,214,692

« Back to Dashboard

Summary for Patent: 7,214,692
Title:Medical use for tachykinin antagonists
Abstract:The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel tachykinin antagonists of formula (I), processes for their preparation, pharmaceutical compositions containing them and their medical use. ##STR00001## wherein R represents the ring A ##STR00002## or 2-pyridinyl or 2-pyridinyl-N-oxide; R.sup.1 is selected from halogen atoms and C.sub.1-4alkyl, C.sub.1-4alkoxy, trifluoromethyl, and S(O).sub.nC.sub.1-4alkyl groups; R.sup.2 and R.sup.3, which may be the same or different, each independently are selected from hydrogen and halogen atoms and C.sub.1-4alkyl, C.sub.1-4alkoxy, trifluoromethyl and cyano groups; n represents zero, 1 or 2; and pharmaceutically acceptable salts and solvates thereof.
Inventor(s): Hagan; Russell Michael (Ware, GB), Bunce; Keith Thomas (Ware, GB)
Assignee: Glaxo Group Limited (Middlesex, GB)
Application Number:09/985,679
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,214,692

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,214,692

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9120172.3Sep 20, 1991
United Kingdom9202839.8Feb 11, 1992
United Kingdom9204151.5Feb 27, 1992

International Patents Family Members for US Patent 7,214,692

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 195867 ➤ Try a Free Trial
Australia 2458392 ➤ Try a Free Trial
Australia 657996 ➤ Try a Free Trial
Canada 2078578 ➤ Try a Free Trial
Germany 69231395 ➤ Try a Free Trial
Denmark 0533280 ➤ Try a Free Trial
European Patent Office 0533280 ➤ Try a Free Trial
European Patent Office 0916346 ➤ Try a Free Trial
European Patent Office 0919245 ➤ Try a Free Trial
European Patent Office 1082959 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
US Army
Cipla
McKesson
Farmers Insurance
Baxter
Deloitte
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot